Stroke prevention study in children with sickle cell anemia, iron overload stopped early

The National Heart, Lung, and Blood Institute (NHLBI) has stopped a clinical trial evaluating a new approach to reduce the risk of recurrent stroke in children with sickle cell anemia and iron overload because of evidence that the new treatment was unlikely to prove better than the existing treatment.

Read the whole article on Physorg

More from Physorg